Clinical development success rates for investigational drugs

被引：1625
|
作者：
Hay, Michael [1 ]
Thomas, David W. [2 ]
Craighead, John L. [3 ]
Economides, Celia [2 ]
Rosenthal, Jesse [1 ]
机构：
[1] Sagient Res Syst, BioMedTracker, San Diego, CA 92122 USA
[2] BIO, Washington, DC USA
[3] Biotech Strategy & Analyt, Rockville, MD USA
来源：
NATURE BIOTECHNOLOGY | 2014年 / 32卷 / 01期
关键词：
PRODUCTIVITY; TRENDS; SCALE; RISKS; SCOPE;
D O I：
10.1038/nbt.2786
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The most comprehensive survey of clinical success rates across the drug industry to date shows productivity may be even lower than previous estimates.
引用
收藏
页码：40 / 51
页数：12
相关论文
共 50 条
  • [21] Investigational drugs in clinical trials for Hidradenitis Suppurativa
    Riis, Peter Theut
    Thorlacius, Linnea R.
    Jemec, Gregor B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (01) : 43 - 53
  • [22] Investigational drugs in development for focal segmental glomerulosclerosis
    Trachtman, Howard
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (08) : 945 - 952
  • [23] Investigational drugs under development for the treatment of PTSD
    Ragen, Benjamin J.
    Seidel, Jordan
    Chollak, Christine
    Pietrzak, Robert H.
    Neumeister, Alexander
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (05) : 659 - 672
  • [24] Early investigational agents for the treatment of rosacea: drugs in phase I and II clinical development
    Moran, Shannon K.
    Wong, Summer C.
    Taylor, Sarah L.
    Feldman, Steven R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2025, 34 (1-2) : 27 - 36
  • [25] Clinical Success versus Attrition of Investigational Pharmaceuticals: A Vignette
    Gupta, Ritu
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2017, 34 (06): : 527 - 549
  • [26] Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results
    Hwang, Thomas J.
    Carpenter, Daniel
    Lauffenburger, Julie C.
    Wang, Bo
    Franklin, Jessica M.
    Kesselheim, Aaron S.
    JAMA INTERNAL MEDICINE, 2016, 176 (12) : 1826 - 1833
  • [27] Investigational drugs for fracture healing: preclinical & clinical data
    Klontzas, Michail E.
    Kenanidis, Eustathios I.
    MacFarlane, Robert J.
    Michail, Theodoros
    Potoupnis, Michael E.
    Heliotis, Manolis
    Mantalaris, Athanasios
    Tsiridis, Eleftherios
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (05) : 585 - 596
  • [28] Clinical development of new drugs for adults and children with cancer in 2010-2020: Longitudinal study of investigational drugs.
    Arfe, Andrea
    Narang, Claire
    DuBois, Steven G.
    Reaman, Gregory H.
    Bourgeois, Florence
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention?
    Mosconi, Maria Giulia
    Paciaroni, Maurizio
    Ageno, Walter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (07) : 645 - 667
  • [30] Post-pancreatitis diabetes mellitus: investigational drugs in preclinical and clinical development and therapeutic implications
    Petrov, Maxim S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (07) : 737 - 747
12345